Risk factors for the development of endometrial lesions in breast cancer patients using tamoxyphen: a retrospective cohort study

Autor: ALVO ORLANDO VIZZOTTO JR, SERGIO MANCINI NICOLAU, GUILHERME MUNHOZ LOPES, ADAUTO CASTELO FILHO

Publikováno v: Revista do Colégio Brasileiro de Cirurgiões, Vol 50 (2023)

ABSTRACT Introduction: breast cancer is the cancer with the highest incidence in women in Brazil, representing 29.7% of all cancers. More than two thirds of women with breast cancer show expression for hormone receptors, and in these cases, hormone t

Externí odkaz: https://doaj.org/article/858dab7d980843428a2087989dcdbdfc

Estudo de coorte retrospectivo para avaliação de fatores de risco para desenvolvimento de lesão endometrial em pacientes com câncer da mama em uso de tamoxifeno

Autor: ALVO ORLANDO VIZZOTTO JR, SERGIO MANCINI NICOLAU, GUILHERME MUNHOZ LOPES, ADAUTO CASTELO FILHO

Publikováno v: Revista do Colégio Brasileiro de Cirurgiões. 50

RESUMO Introdução: o câncer da mama é o câncer de maior incidência no sexo feminino no Brasil, representando 29,7% de todos os cânceres. Mais de dois terços das mulheres com câncer da mama apresentam expressão para receptores hormonais, est

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6827a041cd3e9a11bff21a71d3c3df00
https://doi.org/10.1590/0100-6991e-20233442

Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma:A systematic review and meta-analysis of individual patient data

Autor: Paul A. Cohen, Aime Powell, Steffen Böhm, C. Blake Gilks, Colin J.R. Stewart, Tarek M. Meniawy, Max Bulsara, Stefanie Avril, Eleanor C. Brockbank, Tjalling Bosse, Gustavo Rubino de Azevedo Focchi, Raji Ganesan, Rosalind M. Glasspool, Brooke E. Howitt, Hyun-Soo Kim, Jung-Yun Lee, Nhu D. Le, Michelle Lockley, Ranjit Manchanda, Trupti Mandalia, W. Glenn McCluggage, Iain McNeish, Divya Midha, Radhika Srinivasan, Yun Yi Tan, Rachael van der Griend, Mayu Yunokawa, Gian F. Zannoni, Naveena Singh, Simi Aggarwal, Holger Bronger, Elizabeth B. Brown, Martin Buck, Syed A. Bukhari, Edwina Coghlan, Nichola Cope, Michelle Samora de Almeida, Cornelius D. De Kroon, Andrew Dean, Michael-John Devlin, Helena M. Ditzel, Enken Drecoll, Takahiro Ebata, Anna Fagotti, Asma Faruqi, Laura Feeney, Kavita Gupta, Ian Harley, Frediano Inzani, Arjun R. Jeyarajah, M.H. Eleanor Koay, Judith R. Kroep, Yee Leung, Alice R. Loft, Daniel MaGee, Sarah McKenna, David Millan, Joanne Millar, Rowan Miller, Ganendra R. Mohan, Sohail Mughal, Asima Mukhopadhyay, Sergio Mancini Nicolau, James Nevin, Abigail S. Oakley, Mary Quigley, Bhavana Rai, Arvind Rajwanshi, Stuart G. Salfinger, Giovanni Scambia, Kate Scatchard, Barbara Schmalfeldt, Bryony Simcock, Priya Singh, Kyle C. Strickland, Vainta Suri, Sheeba Syed, Peter Sykes, Kenji Tamura, Adeline Tan, Jason Tan, Emily Thompson, Anna V. Tinker, Georgia Trevisan, Maria Gabriela Baumgarten Kuster Uyeda, Michelle M. Vaughan, Wilko Weichert, Anthony Williams, Sarah Williams, Hiroshi Yoshida, Pier Carlo Zorzato

Publikováno v: Cohen, P A, Powell, A, Böhm, S, Gilks, C B, Stewart, C J R, Meniawy, T M, Bulsara, M, Avril, S, Brockbank, E C, Bosse, T, de Azevedo Focchi, G R, Ganesan, R, Glasspool, R M, Howitt, B E, Kim, H S, Lee, J Y, Le, N D, Lockley, M, Manchanda, R, Mandalia, T, McCluggage, W G, McNeish, I, Midha, D, Srinivasan, R, Tan, Y Y, van der Griend, R, Yunokawa, M, Zannoni, G F, The HGSC CRS Collaborative Network (Supplementary 1) & Møgelbjerg Ditzel, H 2019, ' Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma : A systematic review and meta-analysis of individual patient data ', Gynecologic Oncology, vol. 154, no. 2, pp. 441-448 . https://doi.org/10.1016/j.ygyno.2019.04.679
Gynecologic Oncology, 154(2), 441-448. ACADEMIC PRESS INC ELSEVIER SCIENCE

Objective. There is a need to develop and validate biomarkers for treatment response and survival in tubo-ovarian high-grade serous carcinoma (HGSC). The chemotherapy response score (CRS) stratifies patients into complete/near-complete (CRS3), partia

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00a0a3d918f62859dca88e8d5a6e292c
https://findresearcher.sdu.dk:8443/ws/files/174798070/PIIS0090825819311813.pdf

Immunohistochemical Expression of Heparanases 1 and 2 in Benign Tissue and in Invasive Neoplasia of the Endometrium: A Case-Control Study

Autor: Maria Aparecida da Silva Pinhal, Sergio Mancini Nicolau, Thérèse Rachell Theodoro, Roney Cesar Signorini Filho, Gustavo Rubino de Azevedo Focchi

Publikováno v: International Journal of Gynecologic Cancer. 25:269-278

ObjectivesOur purpose was to compare the expression of heparanase isoforms, in normal and in neoplastic endometrium. In a pioneering way, we sought to evaluate the expression of heparanase 1 (HPSE1) and heparanase 2 (HPSE2) in glandular and in stroma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0efd254895b1c29d4f6c1b1d14101907
https://doi.org/10.1097/igc.0000000000000329

The Immunoexpression of Heparanase 2 in Normal Epithelium, Intraepithelial, and Invasive Squamous Neoplasia of the Cervix

Autor: Sergio Mancini Nicolau, Adauto Castelo, Thérèse Rachell Theodoro, Renato Moretti Marques, Gustavo Rubino de Azevedo Focchi, Maria Aparecida da Silva Pinhal

Publikováno v: Web of Science
Repositório Institucional da UNITAU
Universidade de Taubaté (UNITAU)
instacron:UNITAU

Made available in DSpace on 2019-09-12T16:53:50Z (GMT). No. of bitstreams: 0 Previous issue date: 2012 Objective. Heparanase 2 (HPSE2) is expressed in various tissues, including the brain, intestine, prostate, breast, and endometrium. The aim of this

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3871e999d07db5c4e72d2d803de107fe
https://doi.org/10.1097/lgt.0b013e3182422c69